REQUEST A DEMO
Total
USD $0.00
Search more companies

BENCZE es tarsai Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: BENCZE es tarsai Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

BENCZE es tarsai Bt. is a company based in Hungary, with its head office in Labatlan. The company operates in the Pharmacies and Drug Stores sector. The company was established on February 12, 1996. 4 (2024) employees currently work for BENCZE es tarsai Bt.. In 2024, the company reported a net sales revenue increase of 13.01%. Its’ total assets recorded a growth of 3.41%. BENCZE es tarsai Bt.’s net profit margin decreased by 0.44% in 2024.

Headquarters
Cementgyari lakotelep 34.
Labatlan; Komarom-Esztergom; Postal Code: 2541

Contact Details: Purchase the BENCZE es tarsai Bt. report to view the information.

Basic Information
Total Employees:
Purchase the BENCZE es tarsai Bt. report to view the information.
Registered Capital:
Purchase the BENCZE es tarsai Bt. report to view the information.
Financial Auditors:
Purchase the BENCZE es tarsai Bt. report to view the information.
Incorporation Date:
February 12, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after BENCZE es tarsai Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.01%
Total operating revenue
13.02%
Operating profit (EBIT)
6.17%
EBITDA
6.69%
Net Profit (Loss) for the Period
6.55%
Total Assets
3.41%
Total Equity
7.97%
Operating Profit Margin (ROS)
-0.51%
Net Profit Margin
-0.44%
Return on Equity (ROE)
-0.91%
Quick Ratio
0%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?